Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

[Targeted detecting HER2 expression with recombinant anti HER2 ScFv-GFP fusion antibody].

Gao G, Chen C, Yang Y, Yang H, Wang J, Zheng Y, Huang Q, Hu X.

Sheng Wu Gong Cheng Xue Bao. 2012 Aug;28(8):1002-14. Chinese.

PMID:
23185900
[PubMed - indexed for MEDLINE]
2.

Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.

Ye Q, Hu H, Wang Z, Lu T, Hu Z, Zeng X, Zhang S, Liu J, Lei P, Wang CY, Ye Z, Shen G.

BMC Biotechnol. 2012 Nov 28;12:91. doi: 10.1186/1472-6750-12-91.

PMID:
23192001
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

[Targeted inhibition of rabies virus replication in vitro by single chain antibody domain mediated vector expression shRNA delivery].

Yang R, Cui Y, Yang S, Wang C, Shan H, Wang H, Xia X.

Wei Sheng Wu Xue Bao. 2010 Feb;50(2):256-62. Chinese.

PMID:
20387470
[PubMed - indexed for MEDLINE]
4.

A new vector for controllable expression of an anti-HER2/neu mini-antibody-barnase fusion protein in HEK 293T cells.

Glinka EM, Edelweiss EF, Sapozhnikov AM, Deyev SM.

Gene. 2006 Jan 17;366(1):97-103. Epub 2005 Nov 21.

PMID:
16300908
[PubMed - indexed for MEDLINE]
5.

Intraoperative imaging of metastatic lymph nodes using a fluorophore-conjugated antibody in a HER2/neu-expressing orthotopic breast cancer mouse model.

Wu J, Ma R, Cao H, Wang Z, Jing C, Sun Y, Zhang Y, Yang Z, Hoffman RM, Tang J.

Anticancer Res. 2013 Feb;33(2):419-24.

PMID:
23393332
[PubMed - indexed for MEDLINE]
6.

Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.

Sommaruga S, Lombardi A, Salvadè A, Mazzucchelli S, Corsi F, Galeffi P, Tortora P, Prosperi D.

Appl Microbiol Biotechnol. 2011 Aug;91(3):613-21. doi: 10.1007/s00253-011-3306-3. Epub 2011 May 3.

PMID:
21538107
[PubMed - indexed for MEDLINE]
7.

Construction and characterization of a recombinant human beta defensin 2 fusion protein targeting the epidermal growth factor receptor: in vitro study.

Zhang M, Qiu Z, Li Y, Yang Y, Zhang Q, Xiang Q, Su Z, Huang Y.

Appl Microbiol Biotechnol. 2013 May;97(9):3913-23. doi: 10.1007/s00253-012-4257-z. Epub 2012 Aug 5.

PMID:
22903275
[PubMed - indexed for MEDLINE]
8.

[Construction and expression of human anti-HER2 scFv-9R fusion protein and identification of its activity].

Jiang K, Chen R, Wang LF, Ma Q, Meng YL, Yang AG, Ma BA, Qiu XC.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2011 Nov;27(11):1201-3. Chinese.

PMID:
22078448
[PubMed - indexed for MEDLINE]
9.

Expression, purification, and characterization of anti-plumbagin single-chain variable fragment antibody in Sf9 insect cell.

Sakamoto S, Taura F, Tsuchihashi R, Putalun W, Kinjo J, Tanaka H, Morimoto S.

Hybridoma (Larchmt). 2010 Dec;29(6):481-8. doi: 10.1089/hyb.2010.0052. Epub 2010 Nov 18.

PMID:
21087101
[PubMed - indexed for MEDLINE]
10.

64Cu-DOTA hu4D5v8 (scFv-CH2-CH3)2.

Cheng KT.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2006 Apr 11 [updated 2008 Apr 03].

PMID:
20641754
[PubMed]
Books & Documents
11.

Expression and secretion of a CB4-1 scFv-GFP fusion protein by fission yeast.

Naumann JM, Küttner G, Bureik M.

Appl Biochem Biotechnol. 2011 Jan;163(1):80-9. doi: 10.1007/s12010-010-9018-9. Epub 2010 Jul 10.

PMID:
20617397
[PubMed - indexed for MEDLINE]
12.

Bispecific Her2 × cotinine antibody in combination with cotinine-(histidine)2-iodine for the pre-targeting of Her2-positive breast cancer xenografts.

Yoon S, Kim YH, Kang SH, Kim SK, Lee HK, Kim H, Chung J, Kim IH.

J Cancer Res Clin Oncol. 2014 Feb;140(2):227-33. doi: 10.1007/s00432-013-1548-4. Epub 2013 Dec 1.

PMID:
24292501
[PubMed - indexed for MEDLINE]
13.

Efficient eukaryotic expression of fluorescent scFv fusion proteins directed against CD antigens for FACS applications.

Peipp M, Saul D, Barbin K, Bruenke J, Zunino SJ, Niederweis M, Fey GH.

J Immunol Methods. 2004 Feb 15;285(2):265-80.

PMID:
14980440
[PubMed - indexed for MEDLINE]
14.

RP215 single chain fragment variable and single domain recombinant antibodies induce cell cycle arrest at G0/G1 phase in breast cancer.

Yu F, Wang Y, Xiao Y, He Y, Luo C, Duan D, Li C, Xu S, Xiang T.

Mol Immunol. 2014 May;59(1):100-9. doi: 10.1016/j.molimm.2014.01.007. Epub 2014 Feb 14.

PMID:
24534066
[PubMed - indexed for MEDLINE]
15.

Construction and characterization of an enhanced GFP-tagged anti-BAFF scFv antibody.

Cao M, Cao P, Yan H, Ren F, Lu W, Hu Y, Zhang S.

Appl Microbiol Biotechnol. 2008 Jun;79(3):423-31. doi: 10.1007/s00253-008-1447-9. Epub 2008 Apr 22.

PMID:
18427805
[PubMed - indexed for MEDLINE]
16.

Expression of scFv SA3 against hepatoma fused with enhanced green fluorescent protein and its targeted ability in vivo.

Huang J, Li Y, Guo F, Tong Y, Wang J, Hu J, Li G.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Oct;36(10):979-86. doi: 10.3969/j.issn.1672-7347.2011.10.008.

PMID:
22086009
[PubMed - indexed for MEDLINE]
Free Article
17.

A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia.

Huang TH, Morrison SL.

J Pharmacol Exp Ther. 2006 Mar;316(3):983-91. Epub 2005 Nov 15.

PMID:
16291729
[PubMed - indexed for MEDLINE]
Free Article
18.

Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.

McCall AM, Adams GP, Amoroso AR, Nielsen UB, Zhang L, Horak E, Simmons H, Schier R, Marks JD, Weiner LM.

Mol Immunol. 1999 May;36(7):433-45.

PMID:
10449096
[PubMed - indexed for MEDLINE]
19.

Evaluation of an anti-p185(HER2) (scFv-C(H)2-C(H)3)2 fragment following radioiodination using two different residualizing labels: SGMIB and IB-Mal-D-GEEEK.

Vaidyanathan G, Jestin E, Olafsen T, Wu AM, Zalutsky MR.

Nucl Med Biol. 2009 Aug;36(6):671-80. doi: 10.1016/j.nucmedbio.2009.04.002.

PMID:
19647173
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

DARPins: an efficient targeting domain for lentiviral vectors.

Münch RC, Mühlebach MD, Schaser T, Kneissl S, Jost C, Plückthun A, Cichutek K, Buchholz CJ.

Mol Ther. 2011 Apr;19(4):686-93. doi: 10.1038/mt.2010.298. Epub 2011 Jan 11.

PMID:
21224833
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk